GeneDx Holdings (WGS) Change in Receivables (2020 - 2026)
GeneDx Holdings (WGS) reported Change in Receivables of $2.6 million for Q1 2026, down 70.11% year-over-year from $8.6 million in Q1 2025, and down 80.96% quarter-over-quarter from $13.4 million in Q4 2025.
GeneDx Holdings (WGS) Change in Receivables (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of Change in Receivables data on file, last reported at $2.6 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $2.6 million, down 70.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.2 million (up 68.36% YoY), and the FY2025 annual result was $36.2 million, up 599.44% from the prior year.
- Change in Receivables slipped to $2.6 million in Q1 2026 per WGS's latest filing, from $13.4 million in the prior quarter.
- Over five years, Change in Receivables peaked at $13.4 million in Q4 2025 and troughed at -$13.5 million in Q2 2022.
- A 5-year average of $1.6 million and a median of -$36000.0 in 2022 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 2359.42% in 2024 and fell as far as 435.0% in 2024.
- A 5-year view of Change in Receivables shows it stood at -$36000.0 in 2022, then soared by 655.56% to $200000.0 in 2023, then sank by 435.0% to -$670000.0 in 2024, then soared by 2104.78% to $13.4 million in 2025, then tumbled by 80.96% to $2.6 million in 2026.
- Business Quant data shows WGS's Change in Receivables at $2.6 million in Q1 2026, $13.4 million in Q4 2025, and $12.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -12.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 121.07 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -65.11 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | 2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.56 Mn |
| Mar 31, 2026 | 2.56 Mn |
| Dec 31, 2025 | 13.43 Mn |
| Dec 31, 2025 | 13.43 Mn |
| Sep 30, 2025 | 12.91 Mn |
| Sep 30, 2025 | 12.91 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 8.56 Mn |
| Mar 31, 2025 | 8.56 Mn |
| Dec 31, 2024 | -670,000.00 |
| Dec 31, 2024 | -670,000.00 |
| Sep 30, 2024 | 12.47 Mn |
| Sep 30, 2024 | 12.47 Mn |
| Jun 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | -2.40 Mn |
| Mar 31, 2024 | -4.22 Mn |
| Mar 31, 2024 | -4.22 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |